# FDA 483 - AmerisourceBergen Drug Corp. - June 15, 2023

Source: https://www.globalkeysolutions.net/records/483/amerisourcebergen-drug-corp/22f5053c-7cde-4780-a772-6a323bfda179

> FDA 483 for AmerisourceBergen Drug Corp. on June 15, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AmerisourceBergen Drug Corp.
- Inspection Date: 2023-06-15
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of AmerisourceBergen Drug Corp., a warehouse distributor in Morrisville, NC, revealed significant deficiencies in its operations related to dietary supplements. The firm was cited for lacking quality control for returned supplements, failing to collect reserve samples, and not establishing written procedures for handling returned supplements, as well as for general holding and distribution activities. These observations indicate a lack of adequate controls over the firm's dietary supplement operations.

## Related Officers

- [John E. Aghadia](https://www.globalkeysolutions.net/people/john-e-aghadia/aa33e0e5-fa40-40a5-8fe3-7e1b28120983)

Company: https://www.globalkeysolutions.net/companies/amerisourcebergen-drug-corp/e20bdc98-7510-4048-86b3-df5aa0932d27

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7